nodes	percent_of_prediction	percent_of_DWPC	metapath
Naltrexone—ABCB1—Quinine—malaria	0.0317	0.532	CbGbCtD
Naltrexone—ABCB1—Quinidine—malaria	0.0279	0.468	CbGbCtD
Naltrexone—UGT1A1—blood plasma—malaria	0.0187	0.172	CbGeAlD
Naltrexone—Naloxone—TLR4—malaria	0.0148	1	CrCbGaD
Naltrexone—UGT1A1—hematopoietic system—malaria	0.0103	0.0953	CbGeAlD
Naltrexone—OPRD1—kidney—malaria	0.00978	0.09	CbGeAlD
Naltrexone—UGT1A1—kidney—malaria	0.00848	0.0781	CbGeAlD
Naltrexone—OPRM1—hematopoietic system—malaria	0.00813	0.0749	CbGeAlD
Naltrexone—UGT1A1—digestive system—malaria	0.00719	0.0662	CbGeAlD
Naltrexone—UGT1A1—blood—malaria	0.00685	0.0631	CbGeAlD
Naltrexone—OPRM1—blood—malaria	0.00539	0.0496	CbGeAlD
Naltrexone—UGT1A1—liver—malaria	0.00536	0.0493	CbGeAlD
Naltrexone—OPRD1—brain—malaria	0.0049	0.0452	CbGeAlD
Naltrexone—OPRK1—brain—malaria	0.0047	0.0433	CbGeAlD
Naltrexone—ABCB1—blood plasma—malaria	0.00424	0.0391	CbGeAlD
Naltrexone—OPRM1—brain—malaria	0.00334	0.0308	CbGeAlD
Naltrexone—ABCB1—hematopoietic system—malaria	0.00235	0.0216	CbGeAlD
Naltrexone—ABCB1—kidney—malaria	0.00192	0.0177	CbGeAlD
Naltrexone—Rash—Proguanil—malaria	0.00174	0.00213	CcSEcCtD
Naltrexone—Dermatitis—Proguanil—malaria	0.00174	0.00213	CcSEcCtD
Naltrexone—Headache—Proguanil—malaria	0.00173	0.00212	CcSEcCtD
Naltrexone—Immune system disorder—Quinidine—malaria	0.0017	0.00208	CcSEcCtD
Naltrexone—Immune system disorder—Quinine—malaria	0.0017	0.00208	CcSEcCtD
Naltrexone—Hepatitis—Quinidine barbiturate—malaria	0.0017	0.00208	CcSEcCtD
Naltrexone—Mediastinal disorder—Quinine—malaria	0.0017	0.00208	CcSEcCtD
Naltrexone—Mediastinal disorder—Quinidine—malaria	0.0017	0.00208	CcSEcCtD
Naltrexone—Hepatitis—Pentoxifylline—malaria	0.0017	0.00208	CcSEcCtD
Naltrexone—Hallucination—Quinidine barbiturate—malaria	0.00169	0.00207	CcSEcCtD
Naltrexone—Chills—Quinine—malaria	0.00169	0.00207	CcSEcCtD
Naltrexone—Chills—Quinidine—malaria	0.00169	0.00207	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Sulfadiazine—malaria	0.00167	0.00204	CcSEcCtD
Naltrexone—Insomnia—Sulfadiazine—malaria	0.00166	0.00203	CcSEcCtD
Naltrexone—Mental disorder—Quinine—malaria	0.00165	0.00202	CcSEcCtD
Naltrexone—Mental disorder—Quinidine—malaria	0.00165	0.00202	CcSEcCtD
Naltrexone—Flatulence—Clindamycin—malaria	0.00165	0.00202	CcSEcCtD
Naltrexone—Malnutrition—Quinidine—malaria	0.00164	0.00201	CcSEcCtD
Naltrexone—Malnutrition—Quinine—malaria	0.00164	0.00201	CcSEcCtD
Naltrexone—Nausea—Proguanil—malaria	0.00164	0.00201	CcSEcCtD
Naltrexone—Dysgeusia—Clindamycin—malaria	0.00164	0.002	CcSEcCtD
Naltrexone—ABCB1—digestive system—malaria	0.00163	0.015	CbGeAlD
Naltrexone—Vision blurred—Dapsone—malaria	0.00163	0.00199	CcSEcCtD
Naltrexone—Back pain—Clindamycin—malaria	0.00162	0.00198	CcSEcCtD
Naltrexone—Muscle spasms—Clindamycin—malaria	0.00161	0.00197	CcSEcCtD
Naltrexone—Decreased appetite—Sulfadiazine—malaria	0.00159	0.00195	CcSEcCtD
Naltrexone—Eye disorder—Quinidine barbiturate—malaria	0.00159	0.00195	CcSEcCtD
Naltrexone—Tinnitus—Quinidine barbiturate—malaria	0.00159	0.00194	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Sulfadiazine—malaria	0.00158	0.00194	CcSEcCtD
Naltrexone—Cardiac disorder—Quinidine barbiturate—malaria	0.00158	0.00193	CcSEcCtD
Naltrexone—ABCB1—blood—malaria	0.00155	0.0143	CbGeAlD
Naltrexone—Vision blurred—Quinine—malaria	0.00155	0.00189	CcSEcCtD
Naltrexone—Vision blurred—Quinidine—malaria	0.00155	0.00189	CcSEcCtD
Naltrexone—Tremor—Quinidine—malaria	0.00154	0.00188	CcSEcCtD
Naltrexone—Tremor—Quinine—malaria	0.00154	0.00188	CcSEcCtD
Naltrexone—Immune system disorder—Quinidine barbiturate—malaria	0.00154	0.00188	CcSEcCtD
Naltrexone—Immune system disorder—Pentoxifylline—malaria	0.00153	0.00188	CcSEcCtD
Naltrexone—Mediastinal disorder—Quinidine barbiturate—malaria	0.00153	0.00188	CcSEcCtD
Naltrexone—Chills—Quinidine barbiturate—malaria	0.00153	0.00187	CcSEcCtD
Naltrexone—Cough—Dapsone—malaria	0.00151	0.00185	CcSEcCtD
Naltrexone—Agitation—Quinine—malaria	0.00151	0.00184	CcSEcCtD
Naltrexone—Agitation—Quinidine—malaria	0.00151	0.00184	CcSEcCtD
Naltrexone—ABCB1—bone marrow—malaria	0.0015	0.0139	CbGeAlD
Naltrexone—Angioedema—Quinidine—malaria	0.0015	0.00183	CcSEcCtD
Naltrexone—Angioedema—Quinine—malaria	0.0015	0.00183	CcSEcCtD
Naltrexone—Gastrointestinal pain—Sulfadiazine—malaria	0.0015	0.00183	CcSEcCtD
Naltrexone—Mental disorder—Quinidine barbiturate—malaria	0.00149	0.00182	CcSEcCtD
Naltrexone—Malnutrition—Quinidine barbiturate—malaria	0.00148	0.00181	CcSEcCtD
Naltrexone—Syncope—Quinine—malaria	0.00147	0.0018	CcSEcCtD
Naltrexone—Syncope—Quinidine—malaria	0.00147	0.0018	CcSEcCtD
Naltrexone—Flatulence—Pentoxifylline—malaria	0.00146	0.00178	CcSEcCtD
Naltrexone—Urticaria—Sulfadiazine—malaria	0.00146	0.00178	CcSEcCtD
Naltrexone—Tension—Quinidine barbiturate—malaria	0.00145	0.00178	CcSEcCtD
Naltrexone—Tension—Pentoxifylline—malaria	0.00145	0.00177	CcSEcCtD
Naltrexone—Palpitations—Quinidine—malaria	0.00145	0.00177	CcSEcCtD
Naltrexone—Palpitations—Quinine—malaria	0.00145	0.00177	CcSEcCtD
Naltrexone—Abdominal pain—Sulfadiazine—malaria	0.00145	0.00177	CcSEcCtD
Naltrexone—Body temperature increased—Sulfadiazine—malaria	0.00145	0.00177	CcSEcCtD
Naltrexone—Dysgeusia—Pentoxifylline—malaria	0.00145	0.00177	CcSEcCtD
Naltrexone—Hypertension—Clindamycin—malaria	0.00144	0.00177	CcSEcCtD
Naltrexone—Loss of consciousness—Quinine—malaria	0.00144	0.00176	CcSEcCtD
Naltrexone—Loss of consciousness—Quinidine—malaria	0.00144	0.00176	CcSEcCtD
Naltrexone—Nervousness—Quinidine barbiturate—malaria	0.00144	0.00176	CcSEcCtD
Naltrexone—Nervousness—Pentoxifylline—malaria	0.00144	0.00176	CcSEcCtD
Naltrexone—Back pain—Pentoxifylline—malaria	0.00143	0.00175	CcSEcCtD
Naltrexone—Convulsion—Quinidine—malaria	0.00142	0.00174	CcSEcCtD
Naltrexone—Convulsion—Quinine—malaria	0.00142	0.00174	CcSEcCtD
Naltrexone—Muscle spasms—Pentoxifylline—malaria	0.00142	0.00174	CcSEcCtD
Naltrexone—Discomfort—Clindamycin—malaria	0.00141	0.00172	CcSEcCtD
Naltrexone—Myalgia—Quinidine—malaria	0.0014	0.00171	CcSEcCtD
Naltrexone—Chest pain—Quinine—malaria	0.0014	0.00171	CcSEcCtD
Naltrexone—Chest pain—Quinidine—malaria	0.0014	0.00171	CcSEcCtD
Naltrexone—Myalgia—Quinine—malaria	0.0014	0.00171	CcSEcCtD
Naltrexone—Vision blurred—Quinidine barbiturate—malaria	0.0014	0.00171	CcSEcCtD
Naltrexone—Vision blurred—Pentoxifylline—malaria	0.00139	0.0017	CcSEcCtD
Naltrexone—Tremor—Quinidine barbiturate—malaria	0.00139	0.0017	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.00139	0.0017	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.00139	0.0017	CcSEcCtD
Naltrexone—Tremor—Pentoxifylline—malaria	0.00138	0.00169	CcSEcCtD
Naltrexone—Tachycardia—Dapsone—malaria	0.00138	0.00169	CcSEcCtD
Naltrexone—Ill-defined disorder—Pentoxifylline—malaria	0.00137	0.00168	CcSEcCtD
Naltrexone—Anaphylactic shock—Clindamycin—malaria	0.00136	0.00167	CcSEcCtD
Naltrexone—Agitation—Quinidine barbiturate—malaria	0.00136	0.00167	CcSEcCtD
Naltrexone—Agitation—Pentoxifylline—malaria	0.00136	0.00166	CcSEcCtD
Naltrexone—Angioedema—Quinidine barbiturate—malaria	0.00135	0.00166	CcSEcCtD
Naltrexone—Angioedema—Pentoxifylline—malaria	0.00135	0.00165	CcSEcCtD
Naltrexone—Hypersensitivity—Sulfadiazine—malaria	0.00135	0.00165	CcSEcCtD
Naltrexone—Confusional state—Quinidine—malaria	0.00135	0.00165	CcSEcCtD
Naltrexone—Confusional state—Quinine—malaria	0.00135	0.00165	CcSEcCtD
Naltrexone—Oedema—Quinidine—malaria	0.00134	0.00164	CcSEcCtD
Naltrexone—Oedema—Quinine—malaria	0.00134	0.00164	CcSEcCtD
Naltrexone—Malaise—Pentoxifylline—malaria	0.00133	0.00163	CcSEcCtD
Naltrexone—Syncope—Quinidine barbiturate—malaria	0.00133	0.00162	CcSEcCtD
Naltrexone—Shock—Quinidine—malaria	0.00132	0.00161	CcSEcCtD
Naltrexone—Shock—Quinine—malaria	0.00132	0.00161	CcSEcCtD
Naltrexone—Nervous system disorder—Quinidine—malaria	0.00131	0.00161	CcSEcCtD
Naltrexone—Nervous system disorder—Quinine—malaria	0.00131	0.00161	CcSEcCtD
Naltrexone—Palpitations—Quinidine barbiturate—malaria	0.00131	0.0016	CcSEcCtD
Naltrexone—Tachycardia—Quinine—malaria	0.00131	0.0016	CcSEcCtD
Naltrexone—Tachycardia—Quinidine—malaria	0.00131	0.0016	CcSEcCtD
Naltrexone—Palpitations—Pentoxifylline—malaria	0.00131	0.0016	CcSEcCtD
Naltrexone—Loss of consciousness—Quinidine barbiturate—malaria	0.0013	0.00159	CcSEcCtD
Naltrexone—Skin disorder—Quinidine—malaria	0.0013	0.00159	CcSEcCtD
Naltrexone—Skin disorder—Quinine—malaria	0.0013	0.00159	CcSEcCtD
Naltrexone—Pruritus—Sulfadiazine—malaria	0.0013	0.00159	CcSEcCtD
Naltrexone—Hyperhidrosis—Quinine—malaria	0.00129	0.00158	CcSEcCtD
Naltrexone—Hyperhidrosis—Quinidine—malaria	0.00129	0.00158	CcSEcCtD
Naltrexone—Convulsion—Quinidine barbiturate—malaria	0.00128	0.00157	CcSEcCtD
Naltrexone—Convulsion—Pentoxifylline—malaria	0.00128	0.00157	CcSEcCtD
Naltrexone—Anorexia—Quinidine—malaria	0.00128	0.00156	CcSEcCtD
Naltrexone—Anorexia—Quinine—malaria	0.00128	0.00156	CcSEcCtD
Naltrexone—Insomnia—Dapsone—malaria	0.00128	0.00156	CcSEcCtD
Naltrexone—Hypertension—Pentoxifylline—malaria	0.00128	0.00156	CcSEcCtD
Naltrexone—Arthralgia—Quinidine barbiturate—malaria	0.00126	0.00154	CcSEcCtD
Naltrexone—Chest pain—Quinidine barbiturate—malaria	0.00126	0.00154	CcSEcCtD
Naltrexone—Myalgia—Quinidine barbiturate—malaria	0.00126	0.00154	CcSEcCtD
Naltrexone—Myalgia—Pentoxifylline—malaria	0.00126	0.00154	CcSEcCtD
Naltrexone—Chest pain—Pentoxifylline—malaria	0.00126	0.00154	CcSEcCtD
Naltrexone—Anxiety—Quinidine barbiturate—malaria	0.00126	0.00154	CcSEcCtD
Naltrexone—Diarrhoea—Sulfadiazine—malaria	0.00125	0.00153	CcSEcCtD
Naltrexone—Anxiety—Pentoxifylline—malaria	0.00125	0.00153	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.00125	0.00153	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.00125	0.00153	CcSEcCtD
Naltrexone—Discomfort—Pentoxifylline—malaria	0.00124	0.00152	CcSEcCtD
Naltrexone—Dry mouth—Pentoxifylline—malaria	0.00123	0.00151	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Quinidine—malaria	0.00122	0.00149	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Quinine—malaria	0.00122	0.00149	CcSEcCtD
Naltrexone—Confusional state—Quinidine barbiturate—malaria	0.00122	0.00149	CcSEcCtD
Naltrexone—Dyspnoea—Clindamycin—malaria	0.00122	0.00149	CcSEcCtD
Naltrexone—Confusional state—Pentoxifylline—malaria	0.00122	0.00149	CcSEcCtD
Naltrexone—ABCB1—liver—malaria	0.00122	0.0112	CbGeAlD
Naltrexone—Oedema—Quinidine barbiturate—malaria	0.00121	0.00148	CcSEcCtD
Naltrexone—Anaphylactic shock—Pentoxifylline—malaria	0.00121	0.00148	CcSEcCtD
Naltrexone—Oedema—Pentoxifylline—malaria	0.00121	0.00148	CcSEcCtD
Naltrexone—Infection—Pentoxifylline—malaria	0.0012	0.00147	CcSEcCtD
Naltrexone—Dyspnoea—Quinidine—malaria	0.00119	0.00146	CcSEcCtD
Naltrexone—Dyspnoea—Quinine—malaria	0.00119	0.00146	CcSEcCtD
Naltrexone—Shock—Quinidine barbiturate—malaria	0.00119	0.00145	CcSEcCtD
Naltrexone—Shock—Pentoxifylline—malaria	0.00119	0.00145	CcSEcCtD
Naltrexone—Nervous system disorder—Quinidine barbiturate—malaria	0.00118	0.00145	CcSEcCtD
Naltrexone—Tachycardia—Quinidine barbiturate—malaria	0.00118	0.00144	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Clindamycin—malaria	0.00118	0.00144	CcSEcCtD
Naltrexone—Tachycardia—Pentoxifylline—malaria	0.00118	0.00144	CcSEcCtD
Naltrexone—Fatigue—Clindamycin—malaria	0.00118	0.00144	CcSEcCtD
Naltrexone—Skin disorder—Quinidine barbiturate—malaria	0.00117	0.00144	CcSEcCtD
Naltrexone—Skin disorder—Pentoxifylline—malaria	0.00117	0.00143	CcSEcCtD
Naltrexone—Hyperhidrosis—Quinidine barbiturate—malaria	0.00117	0.00143	CcSEcCtD
Naltrexone—Pain—Clindamycin—malaria	0.00117	0.00143	CcSEcCtD
Naltrexone—Constipation—Clindamycin—malaria	0.00117	0.00143	CcSEcCtD
Naltrexone—Hyperhidrosis—Pentoxifylline—malaria	0.00117	0.00143	CcSEcCtD
Naltrexone—Vomiting—Sulfadiazine—malaria	0.00117	0.00143	CcSEcCtD
Naltrexone—Decreased appetite—Quinidine—malaria	0.00116	0.00142	CcSEcCtD
Naltrexone—Decreased appetite—Quinine—malaria	0.00116	0.00142	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Quinine—malaria	0.00116	0.00141	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Quinidine—malaria	0.00116	0.00141	CcSEcCtD
Naltrexone—Rash—Sulfadiazine—malaria	0.00116	0.00141	CcSEcCtD
Naltrexone—Dermatitis—Sulfadiazine—malaria	0.00115	0.00141	CcSEcCtD
Naltrexone—Gastrointestinal pain—Dapsone—malaria	0.00115	0.00141	CcSEcCtD
Naltrexone—Anorexia—Quinidine barbiturate—malaria	0.00115	0.00141	CcSEcCtD
Naltrexone—Anorexia—Pentoxifylline—malaria	0.00115	0.00141	CcSEcCtD
Naltrexone—Headache—Sulfadiazine—malaria	0.00115	0.00141	CcSEcCtD
Naltrexone—Gastrointestinal pain—Clindamycin—malaria	0.00112	0.00137	CcSEcCtD
Naltrexone—Abdominal pain—Dapsone—malaria	0.00112	0.00136	CcSEcCtD
Naltrexone—Body temperature increased—Dapsone—malaria	0.00112	0.00136	CcSEcCtD
Naltrexone—Feeling abnormal—Quinidine—malaria	0.0011	0.00135	CcSEcCtD
Naltrexone—Feeling abnormal—Quinine—malaria	0.0011	0.00135	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.0011	0.00135	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Pentoxifylline—malaria	0.0011	0.00134	CcSEcCtD
Naltrexone—Gastrointestinal pain—Quinine—malaria	0.00109	0.00134	CcSEcCtD
Naltrexone—Gastrointestinal pain—Quinidine—malaria	0.00109	0.00134	CcSEcCtD
Naltrexone—Insomnia—Pentoxifylline—malaria	0.00109	0.00134	CcSEcCtD
Naltrexone—Nausea—Sulfadiazine—malaria	0.00109	0.00133	CcSEcCtD
Naltrexone—Urticaria—Clindamycin—malaria	0.00108	0.00133	CcSEcCtD
Naltrexone—Abdominal pain—Clindamycin—malaria	0.00108	0.00132	CcSEcCtD
Naltrexone—Body temperature increased—Clindamycin—malaria	0.00108	0.00132	CcSEcCtD
Naltrexone—Dyspnoea—Quinidine barbiturate—malaria	0.00108	0.00132	CcSEcCtD
Naltrexone—Dyspnoea—Pentoxifylline—malaria	0.00108	0.00132	CcSEcCtD
Naltrexone—Somnolence—Quinidine barbiturate—malaria	0.00107	0.00131	CcSEcCtD
Naltrexone—Somnolence—Pentoxifylline—malaria	0.00107	0.00131	CcSEcCtD
Naltrexone—Urticaria—Quinidine—malaria	0.00106	0.0013	CcSEcCtD
Naltrexone—Urticaria—Quinine—malaria	0.00106	0.0013	CcSEcCtD
Naltrexone—Abdominal pain—Quinine—malaria	0.00106	0.0013	CcSEcCtD
Naltrexone—Body temperature increased—Quinine—malaria	0.00106	0.0013	CcSEcCtD
Naltrexone—Body temperature increased—Quinidine—malaria	0.00106	0.0013	CcSEcCtD
Naltrexone—Abdominal pain—Quinidine—malaria	0.00106	0.0013	CcSEcCtD
Naltrexone—Decreased appetite—Quinidine barbiturate—malaria	0.00105	0.00129	CcSEcCtD
Naltrexone—Decreased appetite—Pentoxifylline—malaria	0.00105	0.00128	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.00104	0.00128	CcSEcCtD
Naltrexone—Pain—Quinidine barbiturate—malaria	0.00103	0.00126	CcSEcCtD
Naltrexone—Constipation—Quinidine barbiturate—malaria	0.00103	0.00126	CcSEcCtD
Naltrexone—Constipation—Pentoxifylline—malaria	0.00103	0.00126	CcSEcCtD
Naltrexone—Hypersensitivity—Clindamycin—malaria	0.00101	0.00123	CcSEcCtD
Naltrexone—Feeling abnormal—Quinidine barbiturate—malaria	0.000996	0.00122	CcSEcCtD
Naltrexone—Feeling abnormal—Pentoxifylline—malaria	0.000994	0.00122	CcSEcCtD
Naltrexone—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000988	0.00121	CcSEcCtD
Naltrexone—Hypersensitivity—Quinidine—malaria	0.000986	0.00121	CcSEcCtD
Naltrexone—Hypersensitivity—Quinine—malaria	0.000986	0.00121	CcSEcCtD
Naltrexone—Gastrointestinal pain—Pentoxifylline—malaria	0.000986	0.00121	CcSEcCtD
Naltrexone—Asthenia—Clindamycin—malaria	0.000979	0.0012	CcSEcCtD
Naltrexone—Pruritus—Clindamycin—malaria	0.000965	0.00118	CcSEcCtD
Naltrexone—ABCB1—brain—malaria	0.000964	0.00888	CbGeAlD
Naltrexone—Asthenia—Quinine—malaria	0.000961	0.00118	CcSEcCtD
Naltrexone—Asthenia—Quinidine—malaria	0.000961	0.00118	CcSEcCtD
Naltrexone—Urticaria—Quinidine barbiturate—malaria	0.00096	0.00117	CcSEcCtD
Naltrexone—Urticaria—Pentoxifylline—malaria	0.000958	0.00117	CcSEcCtD
Naltrexone—Abdominal pain—Quinidine barbiturate—malaria	0.000955	0.00117	CcSEcCtD
Naltrexone—Body temperature increased—Quinidine barbiturate—malaria	0.000955	0.00117	CcSEcCtD
Naltrexone—Abdominal pain—Pentoxifylline—malaria	0.000953	0.00117	CcSEcCtD
Naltrexone—Body temperature increased—Pentoxifylline—malaria	0.000953	0.00117	CcSEcCtD
Naltrexone—Pruritus—Quinidine—malaria	0.000947	0.00116	CcSEcCtD
Naltrexone—Pruritus—Quinine—malaria	0.000947	0.00116	CcSEcCtD
Naltrexone—Diarrhoea—Clindamycin—malaria	0.000934	0.00114	CcSEcCtD
Naltrexone—Diarrhoea—Quinine—malaria	0.000916	0.00112	CcSEcCtD
Naltrexone—Diarrhoea—Quinidine—malaria	0.000916	0.00112	CcSEcCtD
Naltrexone—Dizziness—Clindamycin—malaria	0.000902	0.0011	CcSEcCtD
Naltrexone—Vomiting—Dapsone—malaria	0.000897	0.0011	CcSEcCtD
Naltrexone—Hypersensitivity—Quinidine barbiturate—malaria	0.00089	0.00109	CcSEcCtD
Naltrexone—Hypersensitivity—Pentoxifylline—malaria	0.000889	0.00109	CcSEcCtD
Naltrexone—Dizziness—Quinidine—malaria	0.000885	0.00108	CcSEcCtD
Naltrexone—Dizziness—Quinine—malaria	0.000885	0.00108	CcSEcCtD
Naltrexone—Headache—Dapsone—malaria	0.000884	0.00108	CcSEcCtD
Naltrexone—Vomiting—Clindamycin—malaria	0.000868	0.00106	CcSEcCtD
Naltrexone—Asthenia—Quinidine barbiturate—malaria	0.000867	0.00106	CcSEcCtD
Naltrexone—Asthenia—Pentoxifylline—malaria	0.000865	0.00106	CcSEcCtD
Naltrexone—Rash—Clindamycin—malaria	0.00086	0.00105	CcSEcCtD
Naltrexone—Dermatitis—Clindamycin—malaria	0.00086	0.00105	CcSEcCtD
Naltrexone—Headache—Clindamycin—malaria	0.000855	0.00105	CcSEcCtD
Naltrexone—Pruritus—Quinidine barbiturate—malaria	0.000855	0.00105	CcSEcCtD
Naltrexone—Pruritus—Pentoxifylline—malaria	0.000853	0.00104	CcSEcCtD
Naltrexone—Vomiting—Quinine—malaria	0.000851	0.00104	CcSEcCtD
Naltrexone—Vomiting—Quinidine—malaria	0.000851	0.00104	CcSEcCtD
Naltrexone—Rash—Quinidine—malaria	0.000844	0.00103	CcSEcCtD
Naltrexone—Rash—Quinine—malaria	0.000844	0.00103	CcSEcCtD
Naltrexone—Dermatitis—Quinidine—malaria	0.000843	0.00103	CcSEcCtD
Naltrexone—Dermatitis—Quinine—malaria	0.000843	0.00103	CcSEcCtD
Naltrexone—Headache—Quinine—malaria	0.000839	0.00103	CcSEcCtD
Naltrexone—Headache—Quinidine—malaria	0.000839	0.00103	CcSEcCtD
Naltrexone—Nausea—Dapsone—malaria	0.000838	0.00103	CcSEcCtD
Naltrexone—Diarrhoea—Quinidine barbiturate—malaria	0.000827	0.00101	CcSEcCtD
Naltrexone—Diarrhoea—Pentoxifylline—malaria	0.000825	0.00101	CcSEcCtD
Naltrexone—Nausea—Clindamycin—malaria	0.000811	0.000992	CcSEcCtD
Naltrexone—Dizziness—Quinidine barbiturate—malaria	0.000799	0.000978	CcSEcCtD
Naltrexone—Dizziness—Pentoxifylline—malaria	0.000798	0.000976	CcSEcCtD
Naltrexone—Nausea—Quinine—malaria	0.000795	0.000973	CcSEcCtD
Naltrexone—Nausea—Quinidine—malaria	0.000795	0.000973	CcSEcCtD
Naltrexone—Vomiting—Quinidine barbiturate—malaria	0.000768	0.00094	CcSEcCtD
Naltrexone—Vomiting—Pentoxifylline—malaria	0.000767	0.000939	CcSEcCtD
Naltrexone—Rash—Quinidine barbiturate—malaria	0.000762	0.000932	CcSEcCtD
Naltrexone—Dermatitis—Quinidine barbiturate—malaria	0.000761	0.000932	CcSEcCtD
Naltrexone—Rash—Pentoxifylline—malaria	0.00076	0.000931	CcSEcCtD
Naltrexone—Dermatitis—Pentoxifylline—malaria	0.00076	0.00093	CcSEcCtD
Naltrexone—Headache—Quinidine barbiturate—malaria	0.000757	0.000926	CcSEcCtD
Naltrexone—Headache—Pentoxifylline—malaria	0.000756	0.000925	CcSEcCtD
Naltrexone—Nausea—Quinidine barbiturate—malaria	0.000718	0.000878	CcSEcCtD
Naltrexone—Nausea—Pentoxifylline—malaria	0.000716	0.000877	CcSEcCtD
